FDA Drug recall D-1454-2019
Testosterone Topical Solution 30mg of testosterone per pump actuation * each actuation delivers 1.5 mL of solution Total contents: 110 mL t…
- FDA Drug
- Class III
- terminated
- Published 2019-07-10
On 2019-07-10 the FDA classified a Class III recall of Testosterone Topical Solution 30mg of testosterone per pump actuation * each actuation delivers 1.5 mL of solution Total contents: 110 mL t… by Invagen Pharmaceuticals, citing defective Container; actuator may improperly function and affect dose delivery.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1454-2019 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2019-06-12 |
| Published | 2019-07-10 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Invagen Pharmaceuticals |
| Distribution | US |
Product
Testosterone Topical Solution 30mg of testosterone per pump actuation * each actuation delivers 1.5 mL of solution Total contents: 110 mL to deliver 90 mL, Manufactured by: Cipla Ltd, Verna Goa, India Manufactured for: Cipla USA, Inc., Sunrise, FL 33323 NDC 69097-363-44
Reason
Defective Container; actuator may improperly function and affect dose delivery.
Identifiers
| ndc | 69097-363-44 |
|---|---|
| code_info | Lot GH80480 and GH80481, exp 3/2020 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1454-2019%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.